Another study reported that HCCs with immune cell stroma exhibit distinct clinical features of dense CD8+ and EBV-positive CD20+ tumor infiltrating lymphocytes (TILs) and have good prognosis [43]. This evidence concerns the gene CD8A and neoplasm.